J Biol Chem, Vol. 274, Issue 30, 20909-20915, July 23, 1999
Cytotoxicity and Site-specific DNA Damage Induced by Nitroxyl
Anion (NO
) in the Presence of Hydrogen Peroxide
IMPLICATIONS FOR VARIOUS PATHOPHYSIOLOGICAL CONDITIONS*
Laurence
Chazotte-Aubert
,
Shinji
Oikawa§,
Isabelle
Gilibert
,
Franca
Bianchini
,
Shosuke
Kawanishi§, and
Hiroshi
Ohshima
¶
From the
Unit of Endogenous Cancer Risk Factors,
International Agency for Research on Cancer, 150 Cours Albert
Thomas, 69372 Lyon Cedex 08, France and the § Department
of Hygiene, Mie University School of Medicine, Mie 514, Japan
 |
ABSTRACT |
Nitroxyl anion (NO
), the
one-electron reduction product of nitric oxide (NO·), is formed
under various physiological conditions. We have used four different
assays (DNA strand breakage, 8-oxo-deoxyguanosine formation in calf
thymus DNA, malondialdehyde generation from 2'-deoxyribose, and
analysis of site-specific DNA damage using 32P-5'-end-labeled DNA fragments of the human p53
tumor suppressor gene and the c-Ha-ras-1
protooncogene) to study the effects of NO
generated from
Angeli's salt on DNA damage. It was found that strong oxidants are
generated from NO
, especially in the presence of
H2O2 plus Fe(III)-EDTA or Cu(II). NO·
released from diethylamine-NONOate had no such effect. Distinct effects
of hydroxyl radical (HO·) scavengers and patterns of
site-specific DNA cleavage caused by Angeli's salt alone or by
Angeli's salt, H2O2 plus metal ion suggest
that NO
acts as a reductant to catalyze the formation of
the HO· from H2O2 plus Fe(III) and
formation of Cu(I)-peroxide complexes with a reactivity similar to
HO· from H2O2 and Cu(II). Angeli's salt
and H2O2 exerted synergistically cytotoxic
effects to MCF-7 cells, determined by lactate dehydrogenase release
assay. Thus NO
may play an important role in the etiology
of various pathophysiological conditions such as inflammation and
neurodegenerative diseases, especially when
H2O2 and transition metallic ions are present.
 |
INTRODUCTION |
Excess production of nitric oxide (NO·) has been implicated
as a cause of diverse pathophysiological conditions such as
inflammation, neurodegenerative diseases, cardiovascular disorders, and
cancer. These detrimental effects of NO· have been attributed to
reactive nitrogen species such as NOx and peroxynitrite
(ONOO
), which are formed by the reaction of NO·
with oxygen and superoxide, respectively. Reactive nitrogen species can
oxidize, nitrate, and nitrosate biomolecules such as proteins, DNA, and
lipids, thus altering their functions. We have recently reported that
NO
, which is the one-electron reduction product of
NO·, can also cause strand breakage and oxidative damage in DNA
in vitro (1). We have proposed that a highly toxic hydroxyl
radical (HO·) generated from the reaction between
NO
and NO· is responsible for the oxidation
reactions (Equations 1 and 2).
|
(Eq. 1)
|
|
(Eq. 2)
|
NO
has been also reported to be cytotoxic, reducing
intracellular glutathione levels and causing DNA strand breakage in
cultured cells (2). However, it can also be converted under
physiological conditions in vitro, as well as in cells, to
NO· and other reactive oxygen and nitrogen species including
superoxide, hydrogen peroxide (H2O2), and peroxynitrite
(3-5), and the actual mechanisms and reactive species responsible for
the cytotoxic effects of NO
have not been established.
Three recent publications have suggested that NO· synthase
generates NO
, which can be then converted to NO·
by superoxide dismutase and other electron acceptors (6-8). NO
can also be produced from S-nitrosothiols
in the presence of thiols (9-11). It has been reported that, in the
absence of oxygen, nitrosylhemoglobin liberates NO
in a
reaction producing methemoglobin (12). Ferrocytochrome c
also reacts with NO· to form ferricytochrome c and
NO
, which may have implications for inhibition of
mitochondrial oxygen consumption by NO· (13). In our previous
reports, NO
was proposed as one of the possible agents
responsible for DNA strand breakage induced by NO· and
catechol-type compounds such as catecholamines, catechol-estrogens, and
certain flavonoids (14). NO
can be formed by one-electron
reduction of NO· by the quinone/hydroquinone redox system in a
manner similar to that of the formation of O
2 from oxygen
(14).
In the present study, we have studied the effects of NO
generated from Angeli's salt (sodium trioxodinitrate,
Na2N2O3) on DNA strand breakage and
DNA base modifications in vitro mediated by
H2O2 in the presence of metallic ions. At physiological
pH, Angeli's salt exists predominantly in the form of the monoanion HN2O3
, which decomposes to
NO
and nitrite (NO2
)
(Equation 3) (15). As HNO is a weak acid (pKa = 4.7), NO
is the predominant form in aqueous solution at
neutral pH (Equation 4) (15).
|
(Eq. 3)
|
|
(Eq. 4)
|
We have found that NO
generated from Angeli's salt
dramatically enhances DNA damage mediated by
H2O2 in the presence of the ferric ion
(Fe(III))-EDTA or copper ion (Cu(II)), indicating that NO
acts as an endogenous reductant to catalyze formation of strong oxidants. Furthermore, Angeli's salt and H2O2
cooperatively exerted cytotoxic effects toward human breast cancer
cells. We discuss possible implications of our findings as a cause of
diverse pathophysiological conditions mediated by activation or
overexpression of NO· synthase.
 |
EXPERIMENTAL PROCEDURES |
Chemicals--
Angeli's salt and diethylamine-NONOate
(DEA-NO)1 were obtained from
Cayman Chemical Co. (Ann Arbor, MI). Plasmid pBR322 was purchased from
Amersham Pharmacia Biotech. [
-32P]ATP (222 TBq/mmol)
was supplied by NEN Life Science Products. Bathocuproinedisulfonic
acid, and
1H-imidazol-1-yloxy,2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide, potassium salt (carboxy-PTIO) were from Dojin Chemicals Co.,
Kumamoto, Japan. All other chemicals including EDTA, ferric chloride,
cuprous chloride, diethylenetriamine pentaacetic acid (DTPA),
8-oxo-2'-deoxyguanosine, 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy free radical (4-OH-TEMPO), potassium ferricyanide (III)
[K3Fe(CN)6], superoxide dismutase (from
bovine erythrocytes), catalase (from bovine liver, thymol-free), and
2-thiobarbituric acid were obtained from Sigma, Aldrich, or Wako
Chemical Industries, Ltd., Osaka, Japan.
Measurement of Malondialdehyde (MDA) Produced from Oxidation of
Deoxyribose by Angeli's Salt--
MDA formed from the oxidation of
2'-deoxyribose was measured as a marker of HO· generation,
according to the method of Hogg et al. (16). The reactions
were carried out in 100 mM sodium phosphate buffer, pH 7.4, containing 10 µM DTPA, 1 mM 2'-deoxyribose,
500 µM H2O2, 50 µM
either FeCl3-EDTA or CuCl2, an appropriate
amount of HCl to neutralize the NaOH present in the Angeli's salt
solution, and 200 µM Angeli's salt prepared in 0.01 N
NaOH at 37 °C (final volume, 1 ml; final pH, ~7.5). The MDA
content was determined after reaction with 2-thiobarbituric acid using
HPLC with a fluorescence detector, as reported previously (1, 17). All
experiments were carried out in triplicate.
Analysis of 8-oxo-2'-Deoxyguanosine (8-oxo-dG) in Calf Thymus DNA
Incubated with Angeli's Salt--
Angeli's salt prepared in 0.01 N
NaOH (0-5 mM, 100 µl) was added to a reaction mixture
(final volume, 1 ml) containing 0.1 M sodium phosphate
buffer, pH 7.5, calf thymus DNA (1 mg), 10 µM DTPA, 500 µM H2O2, either 50 µM FeCl3-EDTA or CuCl2, and an appropriate amount of HCl to neutralize the NaOH present in the Angeli's salt solution (final pH ~7.5), and the solution was
incubated at 37 °C for 30 min. After the reaction,
ethanol-precipitated DNA was hydrolyzed enzymatically, and 8-oxo-dG and
2'-deoxyguanosine were analyzed by HPLC with a Coulochem II
electrochemical detector (ESA Inc., Chelmsford, MA) and a Shimadzu UV
spectrophotometer (model SPD-2A), respectively, according to a
modification of the method of Yamaguchi et al. (18). All
experiments were carried out in duplicate or triplicate.
Induction and Analysis of DNA Single Strand Breaks--
The
experiments were carried out by incubating plasmid pBR322 DNA (100 ng)
at 37 °C for 30 min in 100 mM sodium phosphate buffer,
pH 7.4, containing 10 µM DTPA, 500 µM
H2O2, either 50 µM
FeCl3-EDTA or CuCl2, 200 µM Angeli's salt prepared in 0.01 N NaOH, and an
appropriate amount of HCl to neutralize the NaOH present in the
Angeli's salt solution (final volume, 10 µl; final pH, ~7.5).
After the reaction, electrophoresis was carried out as described
previously (1, 14, 19-21). The average number of single strand
breaks/pBR322 DNA molecule was calculated according to Epe and
co-workers (22, 23), taking into account that the relaxed form (form
II) when stained with ethidium bromide gives a fluorescence intensity
1.4-fold higher than the supercoiled form (form I) and that a
relaxation is caused by one single strand break/DNA molecule. All
experiments were carried out in triplicate, and statistical
significance was calculated using the Student's t test.
Site-specific DNA Damage--
32P-5'-end-labeled DNA
fragments of the human p53 tumor suppressor
gene2 and the
c-Ha-ras-1 protooncogene (25) were prepared as previously reported (26, 27). The standard reaction mixture in a microtube (1.5-ml, Eppendorf) contained 100 µM Angeli's salt, 20 µM CuCl2, 20 µM
H2O2, 20 µM/base of sonicated
calf thymus DNA, and a 32P-5'-end-labeled DNA fragment in
200 µl of 10 mM sodium phosphate buffer (pH 7.8)
containing 5 µM DTPA. After incubation at 37 °C for 30 min, the DNA fragments were heated at 90 °C in 1 M
piperidine and treated as described previously (26). The treated DNA
fragments were electrophoresed on an 8% polyacrylamide/8 M
urea gel, and the autoradiogram was obtained by exposing x-ray film to
the gel. The preferred cleavage sites were determined by direct
comparison of the positions of the oligonucleotides with those produced
by the procedure of Maxam and Gilbert (28) using a DNA-sequencing system (LKB 2010 Macrohor). A laser densitometer (LKB 2222 UltroScan XL) was used for the measurement of the relative amounts of
oligonucleotides from treated DNA fragments.
Lactate Dehydrogenase (LDH) Cytotoxicity Assay--
Human breast
cancer cells (MCF-7) were cultured in Dulbecco's modified Eagle's
medium, (Life Technologies, Inc.) supplemented with 10% fetal bovine
serum, 2 mM glutamine, 100 units/ml penicillin, and 100 µg/ml streptomycin at 37 °C in a humidified atmosphere containing
10% CO2. Cells were seeded into 96-well microculture plates one day before the treatment, at a density of 105
cells/well with 100 µl of Dulbecco's modified Eagle's medium without phenol red containing 5% fetal bovine serum. Cells were treated with Angeli's salt or DEA-NO prepared in 0.01 N NaOH in combination with H2O2 prepared in water (0-10
mM). The NaOH present in the Angeli's salt or DEA-NO
solutions was neutralized with the same volume of 0.01 N HCl. The LDH
assay was performed using the CytoTox Non-Radioactive Cytotoxicity
Assay (Promega, Madison, WI). To obtain maximal LDH release, nontreated
cells were incubated in the presence of lysis solution (9% Triton
X-100) for 45 min at 37 °C. After 4.5 h of incubation in the
presence of the different products, the plate was centrifuged at
250 × g for 4 min, and 50 µl of supernatant was used
for the LDH assay. The percentage of cytotoxicity was calculated
according to the following equation,
|
(Eq. 5)
|
where exp = experimental value, max = mean of cell
maximum LDH release, back1 = mean of cell culture
background, and back2 = mean of cell culture background
plus lysis solution. All experiments were carried out at
least in triplicate, and the results are expressed as means ± S.D.
 |
RESULTS |
Four different assays were used to study the effects of Angeli's
salt on oxidation reactions mediated by H2O2 in
the presence of Fe(III)-EDTA or Cu(II).
MDA Production from 2'-Deoxyribose--
The first assay was based
on oxidation of 2'-deoxyribose leading to the formation of MDA, which
has been measured as a marker of HO· generation (29). The
formation of MDA in the presence of Angeli's salt,
H2O2, and Fe(III)-EDTA was very rapid and
reached a plateau in 10 min, whereas H2O2 and
Fe(III)-EDTA alone catalyzed the formation of MDA linearly up to 60 min
of incubation (Fig. 1A). Lower
concentrations of MDA were formed when the reaction was carried out in
the presence of H2O2 plus Cu(II) than with
H2O2 plus Fe(III)-EDTA. MDA was also formed
dose dependently with different concentrations of Angeli's salt in
the presence of H2O2 and metallic ions (Fig. 1B). However, its formation was inhibited by a high
concentration (2 mM) of Angeli's salt, especially when the
reaction was carried out in the presence of Fe(III)-EDTA. Fig.
2 compares the levels of MDA formation
mediated by H2O2 and metallic ion in the
presence of Angeli's salt, DEA-NO, or some reducing agents.
NO
generated from Angeli's salt catalyzed MDA formation
from 2'-deoxyribose, as did other reducing agents such as ascorbic
acid, glutathione, and NAD(P)H. In contrast, NO· generated from
200 µM DEA-NO inhibited MDA formation mediated by 500 µM H2O2 and 50 µM
Fe(III)-EDTA or Cu(II) by 43 and 19%, respectively (Fig. 2). Formation
of MDA from 2'-deoxyribose mediated by 200 µM Angeli's
salt, 500 µM H2O2, and 50 µM Fe(III)-EDTA was also inhibited by 83 and 80% by the
inclusion of 200 µM ferricyanide or 4-OH-TEMPO (electron
acceptors), respectively (data not shown).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of incubation time
(A) and Angeli's salt concentrations
(B) on MDA formation from 2'-deoxyribose by
H2O2 and Fe(III)-EDTA or Cu(II).
A, the reactions were carried out in 100 mM
sodium phosphate buffer, pH 7.4, containing 10 µM DTPA, 1 mM 2'-deoxyribose at 37 °C (final volume, 1 ml; final
pH, ~7.5) in the presence of 200 µM Angeli's salt, 500 µM H2O2, and 50 µM
FeCl3-EDTA ( ); 500 µM
H2O2 and 50 µM
FeCl3-EDTA ( ); 200 µM Angeli's salt, 500 µM H2O2, and 50 µM
CuCl2 ( ); and 500 µM
H2O2 and 50 µM CuCl2
( ). B, the reactions were carried out at 37 °C for 10 min in the presence of Angeli's salt alone ( ) and Angeli's salt
plus 50 µM FeCl3-EDTA ( ); Angeli's salt
plus 500 µM H2O2 (x); Angeli's
salt plus 50 µM FeCl3-EDTA and 500 µM H2O2 ( ); Angeli's salt
plus 50 µM CuCl2 ( ); and Angeli's salt
plus 50 µM CuCl2 and 500 µM
H2O2 ( ). The MDA contents were determined
after the reaction with 2-thiobarbituric acid using HPLC with a
fluorescence detector, as reported previously (1, 17). All experiments
were carried out in triplicate.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Comparison of the effect of Angeli's salt
and DEA-NO with that of other reducing agents on MDA formation from
2'-deoxyribose by H2O2 and Fe(III)-EDTA or
Cu(II). The reactions were carried out in 100 mM
sodium phosphate buffer, pH 7.4, containing 10 µM DTPA, 1 mM 2'-deoxyribose at 37 °C for 10 min (final volume, 1 ml; final pH, ~7.5). 1, reductant alone; 2, reductant plus 50 µM FeCl3-EDTA;
3, reductant plus 500 µM
H2O2; 4, reductant plus 500 µM H2O2 plus 50 µM
FeCl3-EDTA; 5, reductant plus 50 µM CuCl2; 6, reductant plus 500 µM H2O2 plus 50 µM
CuCl2. The compounds tested were: H2O (none,
Control), Angeli's salt (AS), DEA-NO,
glutathione (GSH), NADH, NADPH, and ascorbic acid
(ASC). The concentrations were 200 µM, except
for GSH, which was 20 µM.
|
|
Formation of 8-oxo-dG in Calf Thymus DNA--
As shown in Fig.
3, the levels of 8-oxo-dG increased dose
dependently in calf thymus DNA incubated with Angeli's salt in the presence of H2O2 and metallic ions. As
previously reported for other reducing agents such as ascorbic acid and
NADH (27), Angeli's salt catalyzed the hydroxylation of
2'-deoxyguanosine in DNA more efficiently in the presence of Cu(II)
than in the presence of Fe(III)-EDTA. As shown in Table
I, hydroxyl radical scavengers (ethanol,
D-mannitol, Me2SO) inhibited 8-oxo-dG formation
mediated by Angeli's salt, H2O2, and
Fe(III)-EDTA more effectively than that mediated by Angeli's salt,
H2O2, and Cu(II). Two electron acceptors,
ferricyanide and 4-OH-TEMPO, also inhibited the formation of 8-oxo-dG
by H2O2 and either Fe(III)-EDTA or Cu(II).
NO· generated from 0.02, 0.2, or 2 mM DEA-NO did not
increase 8-oxo-dG levels in DNA induced with 500 µM
H2O2 and 50 µM Fe(III)-EDTA or
Cu(II), but rather reduced the hydroxylation of deoxyguanosine mediated
by H2O2 and Fe(III)-EDTA or Cu(II) (40-55%
inhibition) (data not shown).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of Angeli's salt concentration on
8-oxo-dG formation in calf thymus DNA. The reactions were carried
out in 0.1 M sodium phosphate buffer, pH 7.5, containing
calf thymus DNA (1 mg) and 10 µM DTPA at 37 °C for 30 min (final volume, 1 ml) in the presence of Angeli's salt alone ( )
and Angeli's salt plus 50 µM FeCl3-EDTA
( ); Angeli's salt plus 500 µM
H2O2 (x); Angeli's salt plus 50 µM FeCl3-EDTA and 500 µM
H2O2 ( ); Angeli's salt plus 50 µM CuCl2 ( ); and Angeli's salt plus 50 µM CuCl2 and 500 µM
H2O2 ( ). After the reaction,
ethanol-precipitated DNA was hydrolyzed enzymatically, and 8-oxo-dG was
analyzed by HPLC with an electrochemical detector, according to a
modification of the method of Yamaguchi et al. (18). Means
of duplicate analyses are shown.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Effects of hydroxyl radical scavengers and electron acceptors on
8-oxo-dG formation in calf thymus DNA incubated with Angeli's salt
plus H2O2 in the presence of Fe(III)-EDTA or
Cu(II)
Calf thymus DNA (1 mg/ml) was incubated with 200 µM
Angeli's salt, 500 µM H2O2, and 50 µM Fe(III)-EDTA or Cu(II) in the presence of HO·
scavengers and electron acceptors in 0.1 M sodium phosphate
buffer (pH 7.4) containing 10 µM DTPA at 37 °C for 30 min. Mean ± S.D. (n = 3) are presented.
|
|
DNA Strand Breakage--
The pBR322 plasmid DNA was incubated with
200 µM Angeli's salt in the presence or absence of 500 µM H2O2 plus 50 µM
Fe(III)-EDTA or Cu(II), and the percentages of form I (supercoiled
form), form II (open ring form), and form III (linear form) were
measured (Table II). As we previously
reported (1), incubation of plasmid pBR322 with Angeli's salt alone
formed 52.6% of form II, corresponding to ~1.25 single strand
breaks/104 bp. Increased levels of DNA strand breakage were
also observed when plasmid DNA was incubated with metallic ions
(Fe(III)-EDTA or Cu(II)) alone or in combination with
H2O2 and Fe(III)-EDTA or Cu(II) compared with
nontreated plasmid. However, the addition of Angeli's salt
dramatically enhanced strand breakage induced by
H2O2 plus Fe(III)-EDTA or Cu(II). In
particular, when the reaction was carried out in the presence of
Angeli's salt, H2O2, and Cu(II), none of forms
I, II, and III were clearly detected, indicating that the DNA was
completely fragmented. When the plasmid was incubated with Angeli's
salt, H2O2, and Fe(III), only forms II and III
were formed, indicating that in addition to single strand breakage, double strand breaks were also induced.
View this table:
[in this window]
[in a new window]
|
Table II
DNA strand breakage induced by Angeli's salt in the absence or
presence of H2O2 and/or Fe(III)-EDTA or Cu(II)
Plasmid pBR322 DNA (100 ng) was incubated in 100 mM sodium
phosphate buffer, pH 7.4, containing 10 µM DTPA at
37 °C for 15 min. Concentrations of compounds used: Angeli's salt
(200 µM), H2O2 (500 µM),
FeCl3-EDTA (50 µM), and CuCl2 (50 µM). Mean ± S.D. (n = 3) are
presented. AS, Angeli's salt.
|
|
Effects of ·OH Scavengers and Bathocuproine on DNA Damage
Induced by Angeli's Salt--
Fig. 4
shows that incubation of the 32P-5'-end-labeled 261-bp
fragment (AvaI* 1645-XbaI 1905) of the
human c-Ha-ras-1 protooncogene with 200 µM
Angeli's salt alone can induce DNA damage (lane 2). Hydroxyl radical scavengers such as ethanol, D-mannitol,
and sodium formate inhibited the damage induced by Angeli's salt
(lanes 3-5). Carboxy-PTIO, an NO·-trapping agent,
which may also scavenge other oxidants (20, 30), inhibited the
Angeli's salt-mediated DNA damage (lane 6), whereas
bathocuproine, a Cu(I)-specific chelating agent, did not affect it
(lane 7). On the other hand, 40 µM Angeli's
salt in the presence of 20 µM CuCl2 and 40 µM H2O2 exerted much stronger effects on the DNA than Angeli's salt alone (lane 8). This
DNA damage was not inhibited by hydroxyl radical scavengers
(lanes 9-11), whereas it was inhibited by carboxy-PTIO and
bathocuproine almost completely (lane 12 and
13).

View larger version (83K):
[in this window]
[in a new window]
|
Fig. 4.
Effects of ·OH scavengers and
bathocuproine on DNA damage induced by Angeli's salt alone
(lanes 2-7) or Angeli's salt in the presence of
H2O2 and Cu(II) (lanes 8-13).
The 32P-5'-end-labeled 261-bp fragment (AvaI*
1645-XbaI 1905) of the human c-Ha-ras-1 was
incubated in 200 µl of 10 mM sodium phosphate buffer at
pH 7.8 containing 5 µM DTPA with Angeli's salt and
CuCl2, H2O2 and 20 µM/base of sonicated calf thymus DNA in the presence of
the scavenger indicated at 37 °C for 30 min. After piperidine
treatment, DNA fragments were analyzed by the method described under
"Experimental Procedures." Lane 1, control; lane
2, 200 µM Angeli's salt alone; lane 3, + 0.8 M ethanol; lane 4, + 0.2 M
D-mannitol; lane 5, + 0.2 M sodium
formate; lane 6, + 500 µM carboxy-PTIO;
lane 7, + 50 µM bathocuproine; lane
8, 40 µM Angeli's salt, 20 µM
CuCl2, and 40 µM
H2O2; lane 9, + 0.8 M
ethanol; lane 10, + 0.2 M
D-mannitol; lane 11, + 0.2 M sodium
formate; lane 12, + 500 µM carboxy-PTIO;
lane 13, + 50 µM bathocuproine.
|
|
Site Preference of DNA Cleavage--
The DNA cleavage sites were
examined using 32P-5'-end-labeled DNA fragments of the
human p53 tumor suppressor gene and the
c-Ha-ras-1 protooncogene by the procedure of Maxam and
Gilbert (28). As seen in Fig. 5,
B and D, Angeli's salt alone caused DNA cleavage at every nucleotide position without marked site preference. On the
other hand, Angeli's salt in the presence of
H2O2 and Cu(II) induced piperidine-labile sites
frequently at thymine residues (Fig. 5, A and C).
The most preferred site was the thymine residue, especially in the
5'-CTG-3', 5'-GTG-3', and 5'-GTA-3' sequences.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 5.
Site preference of DNA cleavage induced by
Angeli's salt alone (B and D) or
Angeli's salt in the presence of H2O2 and
Cu(II) (A and C). The
32P-5'-end-labeled 261-bp fragment (AvaI*
1645-XbaI 1905) from c-Ha-ras-1 (A and
B) or the 211-bp fragment (ApaI
13972-HindIII* 14 182) from p53 (C and
D) in 200 µl of 10 mM sodium phosphate buffer
at pH 7.8 containing 5 µM DTPA and 20 µM
sonicated calf thymus was incubated with Angeli's salt alone or
Angeli's salt in the presence of H2O2 and
Cu(II) at 37 °C for 30 min. After piperidine treatment, DNA
fragments were electrophoresed on an 8% polyacrylamide/8 M
urea gel using a DNA-sequencing system, and the autoradiogram was
obtained by exposing x-ray film to the gel. The relative amounts of
oligonucleotides produced were measured using a laser densitometer (LKB
222) UltroScan XL. The piperidine-labile sites of the treated DNA were
determined by direct comparison with the same DNA fragment after
undergoing DNA sequencing reactions according to the Maxam-Gilbert
procedure (28). The horizontal axis shows the nucleotide number of the
c-Ha-ras-1 protooncogene (25) (A and
B) or the p53 tumor suppressor gene2
(C and D). A and C, 100 µM Angeli's salt + 20 µM CuCl2 + 20 µM H2O2; B and
D, 100 µM Angeli's salt.
|
|
Cytotoxicity--
Human breast cancer cells (MCF-7) were incubated
for 4.5 h with various concentrations of
H2O2 in the presence or absence of 500 µM Angeli's salt or DEA-NO (Fig.
6A). Either 500 µM Angeli's salt or DEA-NO or 0-0.5 mM
H2O2 alone did not elicit significant cytotoxic
effects in MCF-7 cells. However, in the presence of Angeli's salt or
DEA-NO, LDH release was increased by H2O2 dose dependently with the increase reaching 48.6 ± 5.2% and 30.3 ± 0.2%, respectively, at the 500 µM concentration. On
the other hand, Angeli's salt alone showed weak cytotoxic activity
after 4.5 h of incubation. However, increased cytotoxicity was
observed when the cells were analyzed after 8 h of incubation
(data not shown). The presence of H2O2
increased dramatically the cytotoxicity mediated by Angeli's salt. The
increases in LDH release induced by 500 µM
H2O2 alone or 2 mM Angeli's salt
alone were only 9.0 ± 2.0% and 17.0 ± 0.3%, respectively,
but up to 72.4 ± 1.7% when both compounds were incubated
together. Although no cytotoxic effects were found with even the
highest concentration (2 mM) of DEA-NO alone, the presence
of H2O2 also enhanced cytotoxicity mediated by
DEA-NO (Fig. 6B). However, the cytotoxic effect with DEA-NO
plus H2O2 was, in general, weaker than that
with Angeli's salt plus H2O2. It should be
noted that Angeli's salt and DEA-NO have similar half-lives (~2.5
min) under physiological conditions.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of concentrations of
H2O2 (A) and Angeli's salt or
DEA-NO (B) on the cytotoxicity toward MCF-7
cells. A, the cells were incubated for 4.5 h with
various concentrations of H2O2 (0-500
µM) in combination either with 500 µM
Angeli's salt or DEA-NO. B, Angeli's salt or DEA-NO at
various concentrations (0-2 mM) was incubated in the
presence or absence of 500 µM of
H2O2. Results are expressed as the percentage
(mean ± S.D.) of total LDH release into supernatant.
Hatched bar, controls without Angeli's salt or DEA-NO;
open bar, with Angeli's salt; closed bar, with
DEA-NO.
|
|
 |
DISCUSSION |
Four different assays (DNA strand breakage, MDA formation from
oxidation of 2'-deoxyribose, hydroxylation of 2'-deoxyguanosine in DNA,
and analysis of site-specific DNA damage using
32P-5'-end-labeled DNA fragments of the human
p53 tumor suppressor gene and the c-Ha-ras-1
protooncogene) have been used to study the effects of Angeli's salt,
an NO
generating compound (2-5), on DNA damage. It was
found that Angeli's salt alone produced oxidants as previously
reported (1), whereas the presence of H2O2 and
either Fe(III)-EDTA or Cu(II) dramatically enhanced the production of
oxidants mediated by Angeli's salt. NO· generated from DEA-NO
did not enhance the formation of oxidants even in the presence of
H2O2 and metallic ions but rather inhibited it.
Electron acceptors, ferricyanide and 4-OH-TEMPO, which have been
reported to convert NO
to NO· (2), inhibited
Angeli's salt-mediated oxidation reactions even in the presence of
H2O2 and metallic ions, suggesting that NO
, but not NO·, is responsible for the oxidation
reactions. As previously reported for other reducing agents such as
ascorbic acid and NADH (27), Angeli's salt induced DNA strand breakage
and catalyzed the hydroxylation of 2'-deoxyguanosine in DNA more
efficiently in the presence of Cu(II) than in the presence of
Fe(III)-EDTA. Distinct effects of HO· scavengers on the
oxidation reactions mediated by Fe(III)-EDTA and Cu(II) were also
similar to those reported for ascorbic acid, glutathione, and NADH
(27). The DNA cleavage sites examined using
32P-5'-end-labeled DNA fragments of the human
p53 tumor suppressor gene and the c-Ha-ras-1
protooncogene indicate that Angeli's salt alone caused DNA cleavage at
every nucleotide position without marked site preference. This cleavage
pattern was similar to that reported for DNA damage induced by
HO· (with reductants such as ascorbic acid, glutathione, and
NADH in the presence of H2O2 and Fe(III)-EDTA)
(27). On the other hand, Angeli's salt in the presence of
H2O2 and Cu(II) induced damage frequently at
thymine residues, which was also similar to the pattern reported for
DNA damage induced by the reductant, H2O2, and
Cu(II) (27). These findings together lead us to conclude that
NO
can act as a reducing agent to generate strong
oxidants in the presence of H2O2 and transition
metallic ions.
It has been reported that reducing agents such as ascorbic acid and
NADH can reduce transition metallic ions (Mn+1) to their
reduced forms (Mn), which stimulate production of reactive
oxygen species from H2O2 (Equation 6).
|
(Eq. 6)
|
Similarly NO
can act as a reducing agent to reduce
transition metallic ions (Equation 7).
|
(Eq. 7)
|
In the case of Fe(III)-EDTA, the Fenton reaction mediated by
Fe(II) forms HO·, which is responsible for DNA damage (Equation 8), because HO· scavengers effectively inhibit the oxidation
reactions. Conversely, Cu(II)-mediated DNA damage is not inhibited by
HO· scavengers, suggesting that a Cu(I)-peroxide complex, which
exhibits HO·-like activities, may be responsible for the DNA
damage (Equation 9) (27, 31-33).
|
(Eq. 8)
|
|
(Eq. 9)
|
In a previous study (1), we demonstrated that Angeli's salt and
Piloty's acid (NO
-generating compounds) can produce
strong oxidant(s) capable of inducing DNA strand breakage and oxidizing
2'-deoxyribose and calf thymus DNA to form MDA and 8-oxo-dG,
respectively. These results led us to propose that NO
is
a possible endogenous source of HO·, which may be formed either
directly from the reaction product of NO
with NO·
(N2O
2) (Equations 1 and 2) or indirectly through
H2O2 formation (Equations 10 and 11).
|
(Eq. 10)
|
|
(Eq. 11)
|
In the present study, we observed that Angeli's salt alone
induced DNA damage in the absence of H2O2 and
transition metallic ions, confirming our previous findings (1). The
inclusion of both H2O2 and transition metallic
ions, however, synergistically enhanced DNA damage induced by Angeli's
salt. On the other hand, the DNA damage induced by Angeli's salt was
suppressed by the addition of either Fe(III)-EDTA or Cu(II) (Fig. 3),
suggesting that NO
was converted to NO·, which was
inactive in generating oxidant(s) through the above mechanisms via
either Equations 1 and 2 or Equations 10 and 11. In addition,
NO· possibly formed complexes with reduced transition metallic
ions, inhibiting the generation of O
2 and also the formation
of oxidants from H2O2 (19, 34).
Several groups have recently reported that H2O2
and NO· cooperatively enhance their cytotoxic activity toward
hepatoma cells (35), lymphoma cells (36), ovarian cancer cells (37),
and Escherichia coli (38). Using aromatic hydroxylation of
salicylate as an indicator, the reaction of
H2O2 with NO· generated from DEA-NO was
shown to produce an HO·-like oxidant (39). Farias-Eisner
et al. (37) also reported that NO·,
H2O2, and ferric ion in combination produce a
potent oxidant, which can oxidize benzene to produce phenol, and they
proposed the following mechanism for HO· generation (Equations
12-14).
|
(Eq. 12)
|
|
(Eq. 13)
|
|
(Eq. 14)
|
|
(Eq. 15)
|
In contrast, our results demonstrated inhibitory effects of
NO· on the Fenton reaction and no production of oxidants, at
least under our experimental conditions using DEA-NO,
H2O2, and Fe(III)-EDTA or Cu(II) in
vitro. This NO·-mediated inhibition of the Fenton reaction
was in agreement with results from our previous study (19) and others
(34, 40, 41).
On the other hand, Angeli's salt alone at higher concentrations (1 and
2 mM) exerted weak cytotoxicity, as reported for cultured Chinese hamster V79 lung fibroblasts by Wink et al. (2),
whereas no cytotoxic effects were observed with even the highest
concentration (2 mM) of DEA-NO alone under our experimental
conditions. However, the presence of H2O2
increased cooperatively the cytotoxicity mediated by Angeli's salt.
These results are in good agreement with those from our present
in vitro study. This cytotoxic effect is probably because of
the generation of HO· through the Fenton reaction, which could
occur in our cell culture system because
Fe(NO3)3 was present in the medium. Conversely, synergistic cytotoxic effects of DEA-NO and
H2O2 against MCF-7 cells were also observed,
although the effects were, in general, lower than with Angeli's salt
plus H2O2. Similar cooperative effects of
NO· and H2O2 on cytotoxicity were
reported for other types of cells (35-38). These results are not in
agreement with our in vitro study, which showed that DEA-NO
did not generate oxidants even in the presence of
H2O2 and metallic ions. There are several
possible explanations for this discrepancy between in vitro
and in vivo results. One possibility is that DEA-NO plus
H2O2 induced cytotoxicity by a mechanism
independent of HO· formation. For example, NO· inhibits
the mitochondrial respiratory chain reaction, and
H2O2 further enhances its toxicity.
Alternatively, NO· may be converted in cells to
NO
, which exerts toxic effects with
H2O2. NO· has been reported to be
converted to NO
by ferrocytochrome c (13).
In conclusion, we have demonstrated that the NO
-releasing
compound, Angeli's salt, can catalyze the formation of strong oxidants in the presence of H2O2 and metallic ions,
inducing DNA strand breakage, oxidation of DNA to form 8-oxo-dG
in vitro, and exerting cytotoxic effects toward human breast
cancer cells. Recent studies have demonstrated that NO
may be formed in vivo under a variety of physiological
conditions, including by NO· synthase (6-8) and from
S-nitrosothiols (9-11) and nitrosylhemoglobin (12).
NO· can be also converted to NO
in the presence of
biomolecules such as superoxide dismutase (42) and ferrocytochrome
c (13) and by the quinone/hydroquinone redox system in a
manner similar to that of the formation of O
2 from oxygen
(14). As stimulated immune cells including neutrophils and macrophages
can produce H2O2, one can expect that, during an inflammatory process, the formation of both NO
and
H2O2 could enhance dramatically the
anti-microbial and anti-tumoricidal activity. In addition to the
inflammatory process, under a number of pathological conditions
(e.g. ischemia reperfusion injury, etc.), increased
production of reactive oxygen species and activation of NO·
synthase have been shown to occur (24). Activated NO· synthase
produces NO
, which may then encounter
H2O2 to generate strong oxidants, as shown in
this study. Thus NO
may also play an important role as a
cause of diverse pathophysiological conditions such as inflammation,
neurodegenerative diseases, and cardiovascular disorders, especially
when H2O2 and transition metallic ions are
present together.
 |
ACKNOWLEDGEMENTS |
We thank Dr. J. Cheney for editing the
manuscript and P. Collard for secretarial assistance.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.: 33 (0)4 72 73 85 09; Fax: 33 (0)4 72 73 85 75; E-mail: Ohshima@iarc.fr.
2
P. Chumakov, GenBankTM/EBI Data Bank
accession number X54156, 1990.
 |
ABBREVIATIONS |
The abbreviations used are:
DEA-NO, diethylamine-NONOate;
carboxy-PTIO, 1H-imidazol-1-yloxy,2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl
3-oxide;
DTPA, diethylenetriamine pentaacetic acid;
LDH, lactate
dehydrogenase;
MDA, malondialdehyde;
4-OH-TEMPO, 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy free radical;
8-
oxo-dG, 8-oxo-2'-deoxyguanosine;
HPLC, high pressure liquid
chromatography;
bp, base pair(s).
 |
REFERENCES |
| 1.
|
Ohshima, H.,
Gilibert, I.,
and Bianchini, F.
(1999)
Free Radical Biol. Med.
26,
1305-1313[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Wink, D. A.,
Feelisch, M.,
Fukuto, J.,
Chistodoulou, D.,
Jourd'heuil, D.,
Grisham, M. B.,
Vodovotz, Y.,
Cook, J. A.,
Krishna, M.,
DeGraff, W. G.,
Kim, S.,
Gamson, J.,
and Mitchell, J. B.
(1998)
Arch. Biochem. Biophys.
351,
66-74[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Fukuto, J. M.,
Hobbs, A. J.,
and Ignarro, L. J.
(1993)
Biochem. Biophys. Res. Commun.
196,
707-713[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
VanUffelen, B. E.,
Van der Zee, J.,
de Koster, B. M.,
VanSteveninck, J.,
and Elferink, J. G. R.
(1998)
Biochem. J.
330,
719-722
|
| 5.
|
Wink, D. A.,
and Feelisch, M.
(1996)
in
Methods in Nitric Oxide Research
(Feelisch, M.
, and Stamler, J., eds)
, pp. 403-412, John Wiley & Sons, Inc., New York
|
| 6.
|
Hobbs, A. J.,
Fukuto, J. M.,
and Ignarro, L. J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10992-10996[Abstract/Free Full Text]
|
| 7.
|
Schmidt, H. H.,
Hofmann, H.,
Schindler, U.,
Shutenko, Z. S.,
Cunningham, D. D.,
and Feelisch, M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
14492-14497[Abstract/Free Full Text]
|
| 8.
|
Rusche, K. M.,
Spiering, M. M.,
and Marletta, M. A.
(1998)
Biochemistry
37,
15503-15512[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Arnelle, D. R.,
and Stamler, J. S.
(1995)
Arch. Biochem. Biophys.
318,
279-285[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Hogg, N.,
Singh, R. J.,
and Kalyanaraman, B.
(1996)
FEBS Lett.
382,
223-228[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Wong, P. S. Y.,
Hyun, J.,
Fukuto, J. M.,
Shirota, F. N.,
DeMaster, E. G.,
Shoeman, D. W.,
and Nagasawa, H. T.
(1998)
Biochemistry
37,
5362-5371[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Gow, A. J.,
and Stamler, J. S.
(1998)
Nature
391,
169-173[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Sharpe, M. A.,
and Cooper, C. E.
(1998)
Biochem. J.
332,
9-19
|
| 14.
|
Ohshima, H.,
Yoshie, Y.,
Auriol, S.,
and Gilibert, I.
(1998)
Free Radical Biol. Med.
25,
1057-1065[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Bazylinski, D. A.,
and Hollocher, T. C.
(1985)
Inorg. Chem.
24,
4285-4288
[CrossRef] |
| 16.
|
Hogg, N.,
Darley Usmar, V. M.,
Wilson, M. T.,
and Moncada, S.
(1992)
Biochem. J.
281,
419-424
|
| 17.
|
Draper, H. H.,
Squires, E. J.,
Mahmoodi, H.,
Wu, J.,
Agarwal, S.,
and Hadley, M.
(1993)
Free Radical Biol. Med.
15,
353-363[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Yamaguchi, R.,
Hirano, T.,
Asami, S.,
Chung, M. H.,
Sugita, A.,
and Kasai, H.
(1996)
Carcinogenesis
17,
2419-2422[Abstract/Free Full Text]
|
| 19.
|
Yoshie, Y.,
and Ohshima, H.
(1997)
Arch. Biochem. Biophys.
342,
13-21[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Yoshie, Y.,
and Ohshima, H.
(1997)
Chem. Res. Toxicol.
10,
1015-1022[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Vasquez-Vivar, J.,
Santos, A. M.,
Junqueira, V. B.,
and Augusto, O.
(1996)
Biochem. J.
314,
869-876
|
| 22.
|
Epe, B.,
and Hegler, J.
(1994)
Methods Enzymol.
234,
122-131[Medline]
[Order article via Infotrieve]
|
| 23.
|
Epe, B.,
Ballmaier, D.,
Roussyn, I.,
Briviba, K.,
and Sies, H.
(1996)
Nucleic Acids Res.
24,
4105-4110[Abstract/Free Full Text]
|
| 24.
|
Slezak, J.,
Tribulova, N.,
Pristacova, J.,
Uhrik, B.,
Thomas, T.,
Khaper, N.,
Kaul, N.,
and Singal, P. K.
(1995)
Am. J. Pathol.
147,
772-781[Abstract]
|
| 25.
|
Capon, D. J.,
Chen, E. Y.,
Levinson, A. D.,
Seeburg, P. H.,
and Goeddel, D. V.
(1983)
Nature
302,
33-37[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Oikawa, S.,
and Kawanishi, S.
(1996)
Biochemistry
35,
4584-4590[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Oikawa, S.,
and Kawanishi, S.
(1998)
Biochim. Biophys. Acta
1399,
19-30[Medline]
[Order article via Infotrieve]
|
| 28.
|
Maxam, A. M.,
and Gilbert, W.
(1980)
Methods Enzymol.
65,
499-560[Medline]
[Order article via Infotrieve]
|
| 29.
|
Halliwell, B.,
Gutteridge, J. M.,
and Aruoma, O. I.
(1987)
Anal. Biochem.
165,
215-219[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Pfeiffer, S.,
Leopold, E.,
Hemmens, B.,
Schmidt, K.,
Werner, E. R.,
and Mayer, B.
(1997)
Free Radical Biol. Med.
22,
787-794[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Masrwa, M.,
Cohen, H.,
Meyerstein, D.,
Hickman, D. L.,
Bakac, A.,
and Espenson, J. H.
(1988)
J. Am. Chem. Soc.
110,
4293-4297[CrossRef]
|
| 32.
|
Chiu, S. M.,
Xue, L. Y.,
Friedman, L. R.,
and Oleinick, N. L.
(1995)
Biochemistry
34,
2653-2661[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Rodriguez, H.,
Drouin, R.,
Holmquist, G. P.,
O'Connor, T. R.,
Boiteux, S.,
Laval, J.,
Doroshow, J. H.,
and Akman, S. A.
(1995)
J. Biol. Chem.
270,
17633-17640[Abstract/Free Full Text]
|
| 34.
|
Kanner, J.,
Harel, S.,
and Granit, R.
(1991)
Arch. Biochem. Biophys.
289,
130-136[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Ioannidis, I.,
and de Groot, H.
(1993)
Biochem. J.
296,
341-345
|
| 36.
|
Filep, J. G.,
Lapierre, C.,
Lachance, S.,
and Chan, J. S.
(1997)
Biochem. J.
321,
897-901
|
| 37.
|
Farias-Eisner, R.,
Chaudhuri, G.,
Aeberhard, E.,
and Fukuto, J. M.
(1996)
J. Biol. Chem.
271,
6144-6151[Abstract/Free Full Text]
|
| 38.
|
Pacelli, R.,
Wink, D. A.,
Cook, J. A.,
Krishna, M. C.,
DeGraff, W.,
Friedman, N.,
Tsokos, M.,
Samuni, A.,
and Mitchell, J. B.
(1995)
J. Exp. Med.
182,
1469-1479[Abstract/Free Full Text]
|
| 39.
|
Nappi, A. J.,
and Vass, E.
(1998)
Biochim. Biophys. Acta
1380,
55-63[Medline]
[Order article via Infotrieve]
|
| 40.
|
Wink, D. A.,
Cook, J. A.,
Pacelli, R.,
Liebmann, J.,
Krishna, M. C.,
and Mitchell, J. B.
(1995)
Toxicol. Lett. (Amst.)
82-83,
221-226
|
| 41.
|
Goss, S. P.,
Hogg, N.,
and Kalyanaraman, B.
(1995)
Chem. Res. Toxicol.
8,
800-806[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Murphy, M. E.,
and Sies, H.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
10860-10864[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.